Rememax Pharmaceuticals Private Limited
About Rememax Pharmaceuticals Private Limited
Data last updated:
Rememax Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 20 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51909WB2013PTC193479. Its GSTIN is 19AAGCR4199C1Z4 (West Bengal).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rajkumari Khemani and Vinty Khemani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Rafi Ahmed Kidwai Road Park, Kolkata, West Bengal.
As per MCA filings, the company has satisfied charges of ₹71,000 on record. Court records list 4 cases involving the company, including 4 filed by the company; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rememax Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address is in the company report.
- Email
- Registered Address44A Block B 3rd Floor, Rafi Ahmed Kidwai Road Park Street, Kolkata, West Bengal, India – 700016
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Rememax Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Rememax Pharmaceuticals Private Limited
FY 2025 filings availableRememax Pharmaceuticals Private Limited reported revenue of ₹9,407 (down 99% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 73% over five years, including a 99% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rememax Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rememax Pharmaceuticals Private Limited
Rememax Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajkumari Khemani Also directs: Pharmakon Distributors Private Limited | Director | 21 May 2013 | 13 Years 5 Months | Current |
| Vinty Khemani Also directs: Pharmakon Distributors Private Limited | Director | 29 Sep 2015 | 11 Years 1 Months | Current |
| Vineet Khemani | Director | 20 May 2013 | 13 Years 5 Months | Current |
Peer comparison
Rememax Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| VNW Pharmaceuticals Private Limited | ₹10,000 (FY 2024) | -78.0% | Thane, Maharashtra, India | |||
| Encyclia Pharmaceuticals Private Limited | ₹10,000 (FY 2024) | -100.0% | Delhi, India | |||
| Wise Health Pharmaceuticals Private Limited | ₹10,000 (FY 2021) | Jabalpur, Madhya Pradesh, India | ||||
| Cadlac Pharmaceuticals Private Limited | ₹10,000 (FY 2025) | -96.0% | Meerut, Uttar Pradesh, India | |||
| Equidius Pharmaceuticals Private Limited | ₹9,599 (FY 2019) | Pune, Maharashtra, India | ||||
| Rememax Pharmaceuticals Private Limitedthis company | ₹9,407 (FY 2025) | -99.0% | Kolkata, West Bengal, India | |||
| Gunbrj Pharmaceuticals Private Limited | ₹9,000 (FY 2015) | Bangalore, Karnataka, India | ||||
| Apostolos Pharmaceuticals Pvt Ltd | ₹8,789 (FY 2017) | -26.0% | Thane, Maharashtra, India | |||
| Medicode Pharmaceuticals Private Limited | ₹8,619 (FY 2021) | Hyderabad, Telangana, India | ||||
| Vitota Life Sciences & Pharmaceuticals Private Limited | ₹8,200 (FY 2024) | Bhopal, Madhya Pradesh, India | ||||
| Nivera Pharmaceuticals Private Limited | ₹8,031 (FY 2023) | -70.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Rememax Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Rememax Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Rememax Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Jun 2021 | 100461171 | Indian Overseas Bank | ₹71,000 | Satisfied |
To see the full charge records of Rememax Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Rememax Pharmaceuticals Private Limited has 4 court cases on record: 4 filed by Rememax Pharmaceuticals. 2 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 2 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed by the company against individuals | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed by the company against an individual | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed by the company against an individual | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed by the company against an individual | Disposed |
To see the full case history of Rememax Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rememax Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rememax Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAGCR4199C1Z4 | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rememax Pharmaceuticals Private Limited, buy the company report.
Recent activity
Rememax Pharmaceuticals Private Limited has 4 board changes on record since 2013: 3 appointments and 1 cessation. The latest: Vinty Khemani was appointed as Director on 29 Sep 2015.
Frequently asked questions
Rememax Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in specialty, within the trading industry. It was incorporated on 20 May 2013 (13+ years old) and is registered under CIN U51909WB2013PTC193479.
Rememax Pharmaceuticals has 3 current directors:
- Rajkumari Khemani - Director
- Vinty Khemani - Director
- Vineet Khemani - Director
The latest financial statements of Rememax Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Rememax Pharmaceuticals is 19AAGCR4199C1Z4, registered in West Bengal.
The CIN (Corporate Identification Number) of Rememax Pharmaceuticals is U51909WB2013PTC193479. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rememax Pharmaceuticals has 4 court cases on record: 4 filed by the company. 2 are pending.
Rememax Pharmaceuticals was incorporated on 20 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Rememax Pharmaceuticals by revenue are VNW Pharmaceuticals Private Limited, Encyclia Pharmaceuticals Private Limited, Wise Health Pharmaceuticals Private Limited, Cadlac Pharmaceuticals Private Limited, Equidius Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Vinty Khemani was appointed as Director on 29 Sep 2015. Navneet Khemani ceased to be Director on 11 Aug 2014. Rajkumari Khemani was appointed as Director on 21 May 2013. Rememax Pharmaceuticals has 4 board changes on record in total.
The registered office of Rememax Pharmaceuticals is at 44A Block B 3rd Floor, Rafi Ahmed Kidwai Road Park Street, Kolkata, West Bengal, India – 700016.
Rememax Pharmaceuticals operates in the trading industry, in the specialty segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
